Click for best price
Infectious Diseases Molecular Diagnostics Market Size, Share 2023
The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.
This report aims to provide a comprehensive presentation of the global market for Infectious Diseases Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Diseases Molecular Diagnostics. This report contains market size and forecasts of Infectious Diseases Molecular Diagnostics in global, including the following market information:
Global Infectious Diseases Molecular Diagnostics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Infectious Diseases Molecular Diagnostics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Polymerase Chain Reaction PCR Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Infectious Diseases Molecular Diagnostics include Roche, Qiagen, Illumina, Abbott, Hologic, BioMerieux, Danaher (Cepheid), Myriad Genetics and DAAN Gene, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Infectious Diseases Molecular Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Infectious Diseases Molecular Diagnostics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Infectious Diseases Molecular Diagnostics Market Segment Percentages, by Type, 2022 (%)
Polymerase Chain Reaction PCR
Molecular Hybridization
Biochip
Others
Global Infectious Diseases Molecular Diagnostics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Infectious Diseases Molecular Diagnostics Market Segment Percentages, by Application, 2022 (%)
Hospital
Third-party Testing Agency
Others
Global Infectious Diseases Molecular Diagnostics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Infectious Diseases Molecular Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Infectious Diseases Molecular Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Infectious Diseases Molecular Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Qiagen
Illumina
Abbott
Hologic
BioMerieux
Danaher (Cepheid)
Myriad Genetics
DAAN Gene
Agilent
Genomic Health
BD
Foundation Medicine
Outline of Major Chapters:
Chapter 1: Introduces the definition of Infectious Diseases Molecular Diagnostics, market overview.
Chapter 2: Global Infectious Diseases Molecular Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Infectious Diseases Molecular Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Infectious Diseases Molecular Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Infectious Diseases Molecular Diagnostics Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Infectious Diseases Molecular Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Infectious Diseases Molecular Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Infectious Diseases Molecular Diagnostics Overall Market Size
2.1 Global Infectious Diseases Molecular Diagnostics Market Size: 2022 VS 2029
2.2 Global Infectious Diseases Molecular Diagnostics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Infectious Diseases Molecular Diagnostics Players in Global Market
3.2 Top Global Infectious Diseases Molecular Diagnostics Companies Ranked by Revenue
3.3 Global Infectious Diseases Molecular Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Infectious Diseases Molecular Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Infectious Diseases Molecular Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Infectious Diseases Molecular Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Infectious Diseases Molecular Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Infectious Diseases Molecular Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Infectious Diseases Molecular Diagnostics Market Size Markets, 2022 & 2029
4.1.2 Polymerase Chain Reaction PCR
4.1.3 Molecular Hybridization
4.1.4 Biochip
4.1.5 Others
4.2 By Type - Global Infectious Diseases Molecular Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Infectious Diseases Molecular Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Infectious Diseases Molecular Diagnostics Revenue, 2024-2029
4.2.3 By Type - Global Infectious Diseases Molecular Diagnostics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Infectious Diseases Molecular Diagnostics Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Third-party Testing Agency
5.1.4 Others
5.2 By Application - Global Infectious Diseases Molecular Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Infectious Diseases Molecular Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Infectious Diseases Molecular Diagnostics Revenue, 2024-2029
5.2.3 By Application - Global Infectious Diseases Molecular Diagnostics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Infectious Diseases Molecular Diagnostics Market Size, 2022 & 2029
6.2 By Region - Global Infectious Diseases Molecular Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Infectious Diseases Molecular Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Infectious Diseases Molecular Diagnostics Revenue, 2024-2029
6.2.3 By Region - Global Infectious Diseases Molecular Diagnostics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Infectious Diseases Molecular Diagnostics Revenue, 2018-2029
6.3.2 US Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.3.3 Canada Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.3.4 Mexico Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Infectious Diseases Molecular Diagnostics Revenue, 2018-2029
6.4.2 Germany Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.4.3 France Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.4.4 U.K. Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.4.5 Italy Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.4.6 Russia Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.4.7 Nordic Countries Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.4.8 Benelux Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Infectious Diseases Molecular Diagnostics Revenue, 2018-2029
6.5.2 China Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.5.3 Japan Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.5.4 South Korea Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.5.5 Southeast Asia Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.5.6 India Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Infectious Diseases Molecular Diagnostics Revenue, 2018-2029
6.6.2 Brazil Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.6.3 Argentina Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Infectious Diseases Molecular Diagnostics Revenue, 2018-2029
6.7.2 Turkey Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.7.3 Israel Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.7.4 Saudi Arabia Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.7.5 UAE Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
7 Infectious Diseases Molecular Diagnostics Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Infectious Diseases Molecular Diagnostics Major Product Offerings
7.1.4 Roche Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Qiagen
7.2.1 Qiagen Company Summary
7.2.2 Qiagen Business Overview
7.2.3 Qiagen Infectious Diseases Molecular Diagnostics Major Product Offerings
7.2.4 Qiagen Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Qiagen Key News & Latest Developments
7.3 Illumina
7.3.1 Illumina Company Summary
7.3.2 Illumina Business Overview
7.3.3 Illumina Infectious Diseases Molecular Diagnostics Major Product Offerings
7.3.4 Illumina Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Illumina Key News & Latest Developments
7.4 Abbott
7.4.1 Abbott Company Summary
7.4.2 Abbott Business Overview
7.4.3 Abbott Infectious Diseases Molecular Diagnostics Major Product Offerings
7.4.4 Abbott Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Abbott Key News & Latest Developments
7.5 Hologic
7.5.1 Hologic Company Summary
7.5.2 Hologic Business Overview
7.5.3 Hologic Infectious Diseases Molecular Diagnostics Major Product Offerings
7.5.4 Hologic Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Hologic Key News & Latest Developments
7.6 BioMerieux
7.6.1 BioMerieux Company Summary
7.6.2 BioMerieux Business Overview
7.6.3 BioMerieux Infectious Diseases Molecular Diagnostics Major Product Offerings
7.6.4 BioMerieux Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.6.5 BioMerieux Key News & Latest Developments
7.7 Danaher (Cepheid)
7.7.1 Danaher (Cepheid) Company Summary
7.7.2 Danaher (Cepheid) Business Overview
7.7.3 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Major Product Offerings
7.7.4 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Danaher (Cepheid) Key News & Latest Developments
7.8 Myriad Genetics
7.8.1 Myriad Genetics Company Summary
7.8.2 Myriad Genetics Business Overview
7.8.3 Myriad Genetics Infectious Diseases Molecular Diagnostics Major Product Offerings
7.8.4 Myriad Genetics Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.8.5 Myriad Genetics Key News & Latest Developments
7.9 DAAN Gene
7.9.1 DAAN Gene Company Summary
7.9.2 DAAN Gene Business Overview
7.9.3 DAAN Gene Infectious Diseases Molecular Diagnostics Major Product Offerings
7.9.4 DAAN Gene Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.9.5 DAAN Gene Key News & Latest Developments
7.10 Agilent
7.10.1 Agilent Company Summary
7.10.2 Agilent Business Overview
7.10.3 Agilent Infectious Diseases Molecular Diagnostics Major Product Offerings
7.10.4 Agilent Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Agilent Key News & Latest Developments
7.11 Genomic Health
7.11.1 Genomic Health Company Summary
7.11.2 Genomic Health Business Overview
7.11.3 Genomic Health Infectious Diseases Molecular Diagnostics Major Product Offerings
7.11.4 Genomic Health Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.11.5 Genomic Health Key News & Latest Developments
7.12 BD
7.12.1 BD Company Summary
7.12.2 BD Business Overview
7.12.3 BD Infectious Diseases Molecular Diagnostics Major Product Offerings
7.12.4 BD Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.12.5 BD Key News & Latest Developments
7.13 Foundation Medicine
7.13.1 Foundation Medicine Company Summary
7.13.2 Foundation Medicine Business Overview
7.13.3 Foundation Medicine Infectious Diseases Molecular Diagnostics Major Product Offerings
7.13.4 Foundation Medicine Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.13.5 Foundation Medicine Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Infectious Diseases Molecular Diagnostics Market Opportunities & Trends in Global Market
Table 2. Infectious Diseases Molecular Diagnostics Market Drivers in Global Market
Table 3. Infectious Diseases Molecular Diagnostics Market Restraints in Global Market
Table 4. Key Players of Infectious Diseases Molecular Diagnostics in Global Market
Table 5. Top Infectious Diseases Molecular Diagnostics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Infectious Diseases Molecular Diagnostics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Infectious Diseases Molecular Diagnostics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Infectious Diseases Molecular Diagnostics Product Type
Table 9. List of Global Tier 1 Infectious Diseases Molecular Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Infectious Diseases Molecular Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Infectious Diseases Molecular Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Infectious Diseases Molecular Diagnostics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Infectious Diseases Molecular Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Infectious Diseases Molecular Diagnostics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Infectious Diseases Molecular Diagnostics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Infectious Diseases Molecular Diagnostics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2024-2029
Table 30. Roche Company Summary
Table 31. Roche Infectious Diseases Molecular Diagnostics Product Offerings
Table 32. Roche Infectious Diseases Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 33. Roche Key News & Latest Developments
Table 34. Qiagen Company Summary
Table 35. Qiagen Infectious Diseases Molecular Diagnostics Product Offerings
Table 36. Qiagen Infectious Diseases Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 37. Qiagen Key News & Latest Developments
Table 38. Illumina Company Summary
Table 39. Illumina Infectious Diseases Molecular Diagnostics Product Offerings
Table 40. Illumina Infectious Diseases Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 41. Illumina Key News & Latest Developments
Table 42. Abbott Company Summary
Table 43. Abbott Infectious Diseases Molecular Diagnostics Product Offerings
Table 44. Abbott Infectious Diseases Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 45. Abbott Key News & Latest Developments
Table 46. Hologic Company Summary
Table 47. Hologic Infectious Diseases Molecular Diagnostics Product Offerings
Table 48. Hologic Infectious Diseases Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 49. Hologic Key News & Latest Developments
Table 50. BioMerieux Company Summary
Table 51. BioMerieux Infectious Diseases Molecular Diagnostics Product Offerings
Table 52. BioMerieux Infectious Diseases Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 53. BioMerieux Key News & Latest Developments
Table 54. Danaher (Cepheid) Company Summary
Table 55. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Product Offerings
Table 56. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 57. Danaher (Cepheid) Key News & Latest Developments
Table 58. Myriad Genetics Company Summary
Table 59. Myriad Genetics Infectious Diseases Molecular Diagnostics Product Offerings
Table 60. Myriad Genetics Infectious Diseases Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 61. Myriad Genetics Key News & Latest Developments
Table 62. DAAN Gene Company Summary
Table 63. DAAN Gene Infectious Diseases Molecular Diagnostics Product Offerings
Table 64. DAAN Gene Infectious Diseases Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 65. DAAN Gene Key News & Latest Developments
Table 66. Agilent Company Summary
Table 67. Agilent Infectious Diseases Molecular Diagnostics Product Offerings
Table 68. Agilent Infectious Diseases Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 69. Agilent Key News & Latest Developments
Table 70. Genomic Health Company Summary
Table 71. Genomic Health Infectious Diseases Molecular Diagnostics Product Offerings
Table 72. Genomic Health Infectious Diseases Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 73. Genomic Health Key News & Latest Developments
Table 74. BD Company Summary
Table 75. BD Infectious Diseases Molecular Diagnostics Product Offerings
Table 76. BD Infectious Diseases Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 77. BD Key News & Latest Developments
Table 78. Foundation Medicine Company Summary
Table 79. Foundation Medicine Infectious Diseases Molecular Diagnostics Product Offerings
Table 80. Foundation Medicine Infectious Diseases Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 81. Foundation Medicine Key News & Latest Developments
List of Figures
Figure 1. Infectious Diseases Molecular Diagnostics Segment by Type in 2022
Figure 2. Infectious Diseases Molecular Diagnostics Segment by Application in 2022
Figure 3. Global Infectious Diseases Molecular Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Infectious Diseases Molecular Diagnostics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Infectious Diseases Molecular Diagnostics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Infectious Diseases Molecular Diagnostics Revenue in 2022
Figure 8. By Type - Global Infectious Diseases Molecular Diagnostics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Infectious Diseases Molecular Diagnostics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Infectious Diseases Molecular Diagnostics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Infectious Diseases Molecular Diagnostics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Infectious Diseases Molecular Diagnostics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Infectious Diseases Molecular Diagnostics Revenue Market Share, 2018-2029
Figure 16. US Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Infectious Diseases Molecular Diagnostics Revenue Market Share, 2018-2029
Figure 20. Germany Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 21. France Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Infectious Diseases Molecular Diagnostics Revenue Market Share, 2018-2029
Figure 28. China Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 32. India Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Infectious Diseases Molecular Diagnostics Revenue Market Share, 2018-2029
Figure 34. Brazil Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Infectious Diseases Molecular Diagnostics Revenue Market Share, 2018-2029
Figure 37. Turkey Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 41. Roche Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Qiagen Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Illumina Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Abbott Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Hologic Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. BioMerieux Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Myriad Genetics Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. DAAN Gene Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Agilent Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Genomic Health Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. BD Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Foundation Medicine Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
